How Can Phase I Data from the West Accelerate Drug Development in China and Japan? The Science and Practice of Ethnobridging


Sponsored Content

There is great value in global, multi-ethnic approaches to early-phase drug development, and they can accelerate the availability of new therapies in Asia.

Related Content
© 2024 MJH Life Sciences

All rights reserved.